Evidence map›Paper›PMID 16540523›Full record

ArticleMolecular biology of the cell2006

CNF1-induced ubiquitylation and proteasome destruction of activated RhoA is impaired in Smurf1-/- cells.

Laurent Boyer, Laurent Turchi, Benoit Desnues, Anne Doye, Gilles Ponzio, Jean-Louis Mege, Motozo Yamashita, Ying E Zhang, Jacques Bertoglio, Gilles Flatau and 2 more

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Effects of theInternational journal of molecular sciences · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Cell cycle regulation of Rho signaling pathways.Cell cycle (Georgetown, Tex.) · 2012
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Laurent BoyerFaculté de Médecine, Institut National de la Santé et de la Recherche Médicale, U627, 06107 Nice Cedex 2, France.
Laurent Turchi
Benoit Desnues
Anne Doye
Gilles Ponzio
Jean-Louis Mege
Motozo Yamashita
Ying E Zhang
Jacques Bertoglio
Gilles Flatau
Patrice Boquet
Emmanuel Lemichez
Inserm · FRInstitut de Neurobiologie de la Méditerranée · FRNational Cancer Institute · US

Funding

Molecular Mechanisms of TGF-beta Signaling PathwayZIABC010419 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ZHANG, YING E · 2009 to 2025
$14.9M
MOLECULAR MECHANISMS OF TGF-BETA SIGNALING PATHWAYZ01BC010419 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ZHANG, YING · 2000 to 2008
$2.4M
Intramural NIH HHS
6 · The paper itself

Abstract

Ubiquitylation of RhoA has emerged as an important aspect of both the virulence of Escherichia coli producing cytotoxic necrotizing factor (CNF) 1 toxin and the establishment of the polarity of eukaryotic cells. Owing to the molecular activity of CNF1, we have investigated the relationship between permanent activation of RhoA catalyzed by CNF1 and subsequent ubiquitylation of RhoA by Smurf1. Using Smurf1-deficient cells and by RNA interference (RNAi)-mediated Smurf1 knockdown, we demonstrate that Smurf1 is a rate-limiting and specific factor of the ubiquitin-mediated proteasomal degradation of activated RhoA. We further show that the cancer cell lines HEp-2, human embryonic kidney 293 and Vero are specifically deficient in ubiquitylation of either activated Rac, Cdc42, or Rho, respectively. In contrast, CNF1 produced the cellular depletion of all three isoforms of Rho proteins in the primary human cell types we have tested. We demonstrate that ectopic expression of Smurf1 in Vero cells, deficient for RhoA ubiquitylation, restores ubiquitylation of the activated forms of RhoA. We conclude here that Smurf1 ubiquitylates activated RhoA and that, in contrast to human primary cell types, some cancer cell lines have a lower ubiquitylation capacity of specific Rho proteins. Thus, both CNF1 and transforming growth factor-beta trigger activated RhoA ubiquitylation through Smurf1 ubiquitin-ligase.

Indexed as

Bacterial ToxinsCell LineEscherichia coli ProteinsHumansKidneyProteasome Endopeptidase ComplexReverse Transcriptase Polymerase Chain ReactionrhoA GTP-Binding ProteinUbiquitinUbiquitin-Protein LigasesBacterial Toxinscytotoxic necrotizing factor type 1Escherichia coli ProteinsProteasome Endopeptidase ComplexrhoA GTP-Binding ProteinSMURF1 protein, humanUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID16540523
PMCPMC1474842
OpenAlexW2143793532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.